Cutaneous T-cell lymphoma

Treatment Phase: Continuing treatment

Clinical criteria:

  • Patient must have previously received PBS-subsidised treatment with this drug for this condition,

AND

  • Patient must not have developed disease progression while receiving PBS-subsidised treatment with this drug for this condition,

AND

  • The treatment must be the sole PBS-subsidised therapy for this condition.

Note

Applications for authorisation under this restriction may be made in real time using the Online PBS Authorities system (see www.servicesaustralia.gov.au/HPOS) or by telephone by contacting Services Australia on 1800 700 270 (hours of operation 8 a.m. to 5 p.m. Monday to Friday).

Note

No increase in the maximum number of repeats may be authorised.

Note

Special Pricing Arrangements apply.